COMMUNIQUÉS West-GlobeNewswire

TOMI Environmental Solutions, Inc. Announces Relocation of Its U.S. Corporate Headquarters
19/02/2019
BEVERLY HILLS, Calif., Feb. 19, 2019 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. ® (“TOMI”) (OTCQX:TOMZ), a global company that specializes in disinfection and decontamination essentials using its premier [...]
Pernix Therapeutics Holdings, Inc. Enters into Asset Purchase Agreement with Certain Funds Managed by Highbridge Capital Management
19/02/2019
Transaction that includes the sale of substantially all of Pernix’s assets to be valued at $75.6 million Pernix voluntarily files for Chapter 11 protection Pernix intends to continue to operate with no disruption to the [...]
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 janvier 2019
19/02/2019
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 janvier 2019 En application de l'article L. 233-8 II du code de commerce et de l'article 222-12-5 du règlement général de l'AMF, [...]
MediPharm Labs Announces Listing on Frankfurt Stock Exchange
19/02/2019
TORONTO, Feb. 19, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQB: MLCPF) (FSE:MLZ) (“MediPharm”) a leader in specialized, research-driven cannabis extraction, distillation, purification and [...]
Generex Biotechnology Subsidiary Regentys Corporation Receives Approval of Japanese Patent for Extracellular Matrix Hydrogel (Regentys ECMH™)
19/02/2019
MIRAMAR, FL, Feb. 19, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) ( http://www.otcmarkets.com/stock/GNBT/quote ) is pleased to announce that the [...]
Radius Health to Present at Leerink Partners 8th Annual Global Healthcare Conference
19/02/2019
WALTHAM, Mass., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS), today announced that Jesper Høiland, President and CEO of the Company, will present a corporate update at the Leerink Partners 8 th [...]
Innovation Pharmaceuticals Receives New Patent for Compounds for Use in Treatment of Oral Mucositis
19/02/2019
BEVERLY, Mass., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals, (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to report that the U.S. Patent & Trademark Office [...]
RespireRx Pharmaceuticals Inc. and Impression Healthcare Limited Announce Agreement to Explore Commercialization of Dronabinol for the Treatment of Obstructive Sleep Apnea (OSA) in Australia, New Zealand and Southeast Asia
19/02/2019
Glen Rock, N.J., Feb. 19, 2019 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (“RespireRx” or the “Company”), a leader in the research and development of cannabinoids for the treatment of sleep-related [...]
Precision Therapeutics Inc. is Excited to Announce a Special Meeting of Stockholders and Commencement of Registered Exchange Offer
19/02/2019
MINNEAPOLIS, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc . (NASDAQ: AIPT) (“ Precision ”) today announced the effectiveness of its Form S-4 registration statement, the establishment of the date of its [...]
Canada House Wellness Group Announces Unit Financing for $2 to $3 Million
19/02/2019
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (CSE: CHV) (“ Canada House ” or the “ Company ”) announces [...]
Letter to Shareholders from Curt Fairbrother, CEO The Medtainer™
19/02/2019
CORONA, Calif., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Dear Shareholders- I know that you haven’t heard from us in a while, and I apologize for that. I assure you that it was not by omission but by design. The end of 2018 [...]
VistaGen Therapeutics Receives AV-101 Japanese Patent for Treatment of Depression and Hyperalgesia
19/02/2019
SOUTH SAN FRANCISCO, Calif., Feb. 19, 2019 (GLOBE NEWSWIRE) -- VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing new generation medicines for depression and other central [...]
Assertio Therapeutics Announces FDA Notification of Acceptance for Filing of 505(b)(2) NDA for Long-acting Cosyntropin
19/02/2019
Company Anticipates Potential Market Launch by Early 2020 LAKE FOREST, Ill., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) announced today that it has received notification of acceptance [...]
Nuvectra to Report Fourth Quarter and Full Year 2018 Financial Results on February 28, 2019
19/02/2019
PLANO, Texas, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that it will release its financial results for the fourth quarter and full [...]
Cerecor Receives Fast Track Designation from FDA for CERC-801 for the Treatment of PGM1 Deficiency
19/02/2019
ROCKVILLE, Md., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for rare and orphan diseases in [...]
MediPharm Labs Announces Listing on Frankfurt Stock Exchange
19/02/2019
TORONTO, Feb. 19, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQB: MLCPF) (FSE:MLZ) (“MediPharm”) a leader in specialized, research-driven cannabis extraction, distillation, purification and [...]
BrainStorm Issues a Statement to Patients and Shareholders
19/02/2019
NEW YORK, Feb. 19, 2019 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leader in developing innovative autologous cellular therapies for highly debilitating neurodegenerative diseases, in [...]
Cognition Therapeutics Announces Publication of Complete Results from Phase 1 Clinical Trial of Elayta™
19/02/2019
Elayta Crossed Blood Brain Barrier and Reached CNS Levels Associated in Preclinical Studies with Cognitive Improvement Pittsburgh, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. , a clinical stage [...]
Cabaletta Bio Appoints Experienced Financial Executive, Richard Henriques, to its Board of Directors
19/02/2019
RADNOR, Pa., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc., a biotechnology company focused on the discovery and development of cellular therapies for B cell-mediated autoimmune diseases, announced today the [...]

Pages